Frédéric Lamoliatte
Impact in
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Glycosylation and Glycoproteins Research
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 16
- RNA modifications and cancer 4
- Retinoids in leukemia and cellular processes 3
- Oncology 8
- Peptidase Inhibition and Analysis 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Pierre Thibault (7 shared papers)Francis P. McManus (5 shared papers)Mounira K. Chelbi‐Alix (3 shared papers)Ghizlane Maarifi (2 shared papers)Éric Bonneil (2 shared papers)Olivier Caron-Lizotte (2 shared papers)Chantal Durette (2 shared papers)Mohamed Ali Maroui (2 shared papers)
- Journals
- Molecular & Cellular Proteomics (3 papers)Nature Communications (3 papers)Science Advances (3 papers)The EMBO Journal (2 papers)Nature Structural & Molecular Biology (2 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Frédéric Lamoliatte
22 papers receiving 585 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 508
- Oncology 170
- Cell Biology 74
- Immunology 95
- Cancer Research 44
Countries citing papers authored by Frédéric Lamoliatte
This map shows the geographic impact of Frédéric Lamoliatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lamoliatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lamoliatte more than expected).
Fields of papers citing papers by Frédéric Lamoliatte
This network shows the impact of papers produced by Frédéric Lamoliatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lamoliatte. The network helps show where Frédéric Lamoliatte may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Lamoliatte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 116 | |
| 2 | 2014 | 112 | |
| 3 | 2022 | 48 | |
| 4 | 2013 | 42 | |
| 5 | 2022 | 39 | |
| 6 | 2018 | 30 | |
| 7 | 2017 | 30 | |
| 8 | 2017 | 26 | |
| 9 | 2018 | 25 | |
| 10 | 2024 | 23 | |
| 11 | 2024 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2022 | 15 | |
| 14 | 2024 | 12 | |
| 15 | 2023 | 11 | |
| 16 | 2024 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 2 |
About Frédéric Lamoliatte
Frédéric Lamoliatte is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Cancer Research, having authored 23 papers that have together received 586 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), interferon and immune responses (5 papers), RNA modifications and cancer (4 papers), Peptidase Inhibition and Analysis (4 papers), Retinoids in leukemia and cellular processes (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related Molecular Pathways (3 papers) and Advanced Proteomics Techniques and Applications (3 papers). The work is most often cited by research in Molecular Biology (508 citations), Oncology (170 citations), Cell Biology (74 citations), Immunology (95 citations) and Cancer Research (44 citations). Frédéric Lamoliatte has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Pierre Thibault, Francis P. McManus, Mounira K. Chelbi‐Alix, Ghizlane Maarifi, Éric Bonneil, Olivier Caron-Lizotte, Chantal Durette, Mohamed Ali Maroui, Danielle Caron and Yogesh Kulathu. Their work appears in journals such as Molecular & Cellular Proteomics, Nature Communications, Science Advances, The EMBO Journal and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.